Patents Represented by Attorney Morton S. Simon
  • Patent number: 4762704
    Abstract: A topical antiperspirant composition containing an antihistamine selected from the group consisting of antazoline, pyrilamine, tripelennamine, diphenhydramine, phenindamine and their corresponding pharmaceutically acceptable salts and an enhancer for said antihistamine selected from the group consisting of sodium sulfate, glutamic acid; octyl palmitate and propylene glycol methyl ether.
    Type: Grant
    Filed: April 28, 1986
    Date of Patent: August 9, 1988
    Assignee: Bristol-Myers Company
    Inventors: Ronald R. Rafft, Michael D. Helman, Leonard Mackles
  • Patent number: 4757060
    Abstract: A pharmaceutical composition and process for administering non-steroidal drugs which are protected against injury to the gastrointestinal tract by a combination of certain H.sub.1 and H.sub.2 receptor blockers.
    Type: Grant
    Filed: April 29, 1986
    Date of Patent: July 12, 1988
    Assignee: Bristol-Myers Company
    Inventors: Alison B. Lukacsko, Randy J. Koslo, Joseph J. Piala
  • Patent number: 4737361
    Abstract: An antiperspirant process and composition wherein the active antiperspirant ingredient is an alpha adrenergic amine that has at least a substantial alpha.sub.2 adrenergic amine activity component.
    Type: Grant
    Filed: June 6, 1986
    Date of Patent: April 12, 1988
    Assignee: Bristol-Myers Company
    Inventors: Ronald R. Rafft, Michael D. Helman
  • Patent number: 4433710
    Abstract: A plane adapted to cut hinge recesses in a door edge is disclosed. The plane housing has a base having a cutout. A rotary cutter, rotatable relative to the base, is mounted from the base and in alignment with the cutout. Means are provided for selectively adjusting the position of the cutter relative to the base. Limiting means are provided for preventing the cutter from cutting across the entire width of an underlying door edge so that the cutter will leave an uncut strip of door edge after a hinge recess is cut in the door edge by the plane. The uncut strip serves to limit lateral movement of the door hinge when it is mounted in the hinge recess cut by the plane. Means are provided for rotating the cutter, such means comprising a first pulley on the cutter, a second pulley, a tensioned belt engaging both pulleys and drive means for the second pulley.
    Type: Grant
    Filed: October 28, 1981
    Date of Patent: February 28, 1984
    Inventor: Antonio D. Posta
  • Patent number: 4375545
    Abstract: 6-Aminonicotinic acid is reacted with an alkali carbonate selected from the group consisting of sodium carbonate and potassium carbonate. The reaction is carried out at elevated temperature and in dimethylformamide. The 6-aminonicotinic acid alkali salt so produced is reacted with 3-chloromethylpyridine hydrochloride. The reaction is carried out at elevated temperature and in dimethylformamide. The desired nicotinyl ester is thus produced.
    Type: Grant
    Filed: June 22, 1981
    Date of Patent: March 1, 1983
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr., William A. Somerville, F. Christopher Zusi
  • Patent number: 4355028
    Abstract: Procedure for treating acne vulgaris that uses salicylic acid and benzoyl peroxide either sequentially or simultaneously. Compositions for practicing each of these aspects of the invention are also described.
    Type: Grant
    Filed: April 30, 1981
    Date of Patent: October 19, 1982
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Albert M. Kligman, Walter L. McKenzie, Peter F. Ciesla
  • Patent number: 4318907
    Abstract: Procedure for treating acne vulgaris that uses salicylic acid and benzoyl peroxide either sequentially or simultaneously. Compositions for practicing each of these aspects of the invention are also described.
    Type: Grant
    Filed: April 4, 1978
    Date of Patent: March 9, 1982
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Albert M. Kligman, Walter L. McKenzie, Peter F. Ciesla
  • Patent number: 4315023
    Abstract: 1-Phenethylimidazole compounds of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are independently hydrogen or halogen, Z is a mono or disubstituted phenyl moiety of the formula: ##STR2## or a 2 or 3-thienyl moiety of formula: ##STR3## wherein R.sup.3 and R.sup.4 are independently hydrogen, halogen, (lower) alkyl, or trifluoromethyl, with the proviso that R.sup.3 and R.sup.4 can not both be trifluoromethyl and the antimicrobial acid addition salts thereof are useful as antifungal and antibacterial agents.
    Type: Grant
    Filed: December 1, 1980
    Date of Patent: February 9, 1982
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Richard A. Partyka, Thomas W. Hudyma
  • Patent number: 4282206
    Abstract: Reaction of 4-nitrophenacyl bromide with morpholine affords the novel intermediate 1-(4-nitrophenyl)-2-morpholinylethanone which when reduced yields the novel sunscreen 1-(4-aminophenyl)-2-morpholinylethanone.
    Type: Grant
    Filed: November 15, 1979
    Date of Patent: August 4, 1981
    Assignee: Westwood Pharmaceuticals Inc.
    Inventors: Paul L. Warner, Jr., F. Christopher Zusi
  • Patent number: 4249005
    Abstract: Various derivatives of barbituric acid and of diphenylhydantoin are described in which alkoxymethyl or benzyloxymethyl groups are attached to the nitrogen atoms of the rings. Therapeutic compositions containing these compounds and their use as anti-convulsant agents are described.
    Type: Grant
    Filed: December 29, 1969
    Date of Patent: February 3, 1981
    Assignee: Bristol-Myers Company
    Inventors: Carlos M. Samour, Julius A. Vida
  • Patent number: 4236015
    Abstract: A 1-(2-acylaminophenyl)imidazole of formula: ##STR1## wherein R.sup.5 is a cycloaliphatic, phenyl, substituted phenyl group bonded to the carbonyl carbon through a carbon-to-carbon linkage are intermediates for the preparation of 4-substituted imidazo[1,2-a]quinoxalines having anti-inflammatory, immunosuppressant and anti-fungal activity.
    Type: Grant
    Filed: May 7, 1979
    Date of Patent: November 25, 1980
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: 4229452
    Abstract: A method for treating inflammatory disorders in mammals which comprises administering to said mammals having an inflammatory disorder a therapeutically effective amount of 4-trifluoromethylimidazo[1,2-a]quinoxaline.
    Type: Grant
    Filed: July 12, 1979
    Date of Patent: October 21, 1980
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: 4225724
    Abstract: 2(1-imidazolyl)phenylureylene compounds of the formula: ##STR1## wherein R.sup.2 is hydrogen or a radical bonded to the nitrogen by a carbon to nitrogen linkage and selected from the group consisting of aliphatic, cycloaliphatic, phenyl, substituted phenyl, fused bicyclic aryl, and monocyclic aryl substituted aliphatic groups are intermediates for the preparation of 4-substituted amino imidazo[1,2-a]quinoxalines having immunosuppressant activity.
    Type: Grant
    Filed: March 5, 1979
    Date of Patent: September 30, 1980
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: 4200750
    Abstract: A 4-substituted imidazo [1,2-a]quinoxaline of formula: ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sup.1 is bonded to a ring carbon through a carbon-to-carbon linkage and is an aliphatic, cycloaliphatic, substituted phenyl, fused bicyclic aryl; or a monocyclic aryl substituted aliphatic group.
    Type: Grant
    Filed: December 8, 1977
    Date of Patent: April 29, 1980
    Assignee: Westwood Pharmaceuticals Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: 4198508
    Abstract: Preparation of 4-substituted imidazo[1,2-a]quinoxalines by cyclizing a compound of the formula: ##STR1## with phosphorous oxychloride wherein X.sup.2 is a group --R.sup.5 or --NHR.sup.2 where R.sup.5 and R.sup.2 are hydrogen or various organo groups.
    Type: Grant
    Filed: December 8, 1977
    Date of Patent: April 15, 1980
    Assignee: Westwood Pharmaceuticals Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: 4197403
    Abstract: A 4-substituted imidazo[1,2-a]quinoxaline of formula: ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sup.2 is hydrogen or a radical bonded to the nitrogen by a carbon to nitrogen linkage and selected from the group consisting of aliphatic, cycloaliphatic, phenyl, substituted phenyl, fused bicyclic aryl, and monocyclic aryl substituted aliphatic group.
    Type: Grant
    Filed: December 8, 1977
    Date of Patent: April 8, 1980
    Assignee: Westwood Pharmaceuticals Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: 4191766
    Abstract: A method for reducing the immunological response in mammals by the administration of certain substituted phenyl or substituted anilino imidazo[1,2-a]quinoxalines.
    Type: Grant
    Filed: December 8, 1977
    Date of Patent: March 4, 1980
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: 4191767
    Abstract: A method for treating a fungal infection in mammals which comprises administering to said mammals having a fungal infection a therapeutically effective amount of a 4-(substituted phenyl)imidazo[1,2-a]quinoxaline.
    Type: Grant
    Filed: December 8, 1977
    Date of Patent: March 4, 1980
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: 4172947
    Abstract: A 1-(2-acylaminophenyl)imidazole of formula: ##STR1## wherein R.sup.5 is hydrogen or an aliphatic, cycloaliphatic, phenyl, substituted phenyl, fused bicyclic aryl or monocyclic aryl substituted aliphatic group bonded to the carbonyl carbon through a carbon-to-carbon linkage. The compounds are useful as intermediates in the preparation of 4-substituted imidazo[1,2-a]quinoxalines.
    Type: Grant
    Filed: December 8, 1977
    Date of Patent: October 30, 1979
    Assignee: Westwood Pharmaceuticals, Inc.
    Inventors: Paul L. Warner, Jr., Edward J. Luber, Jr.
  • Patent number: D276412
    Type: Grant
    Filed: March 19, 1982
    Date of Patent: November 20, 1984
    Assignee: Bristol-Myers Company
    Inventor: Michael P. Toomey